ENTRY       D05711                      Drug
NAME        Regadenoson (USAN);
            Regadenoson hydrate (JAN);
            Regadenoson monohydrate;
            Lexiscan (TN)
PRODUCT     LEXISCAN (Astellas Pharma US)
            LEXISCAN(R) (REGADENOSON) (HF Acquisition Co LLC)
  GENERIC   REGADENOSON (Almaject)
            REGADENOSON (Baxter Healthcare Corporation)
            REGADENOSON (Gland Pharma Limited)
            REGADENOSON (Hikma Pharmaceuticals USA)
            REGADENOSON (Meitheal Pharmaceuticals)
            REGADENOSON (Mylan Institutional LLC)
FORMULA     C15H18N8O5. H2O
EXACT_MASS  408.1506
MOL_WEIGHT  408.3693
REMARK      ATC code: C01EB21
            Chemical structure group: DG03262
            Product (DG03262): D12568<US> D05711<US>
EFFICACY    Vasodilator (coronary), Adenosine A2a receptor agonist
COMMENT     Coronary vasodilator for intravenous use as an adjunct, or pharmacologic stress agent, in radionuclide myocardial perfusion imaging in patients unable to exercise adequately
TARGET      ADORA2A [HSA:135] [KO:K04266]
  PATHWAY   hsa04024(135)  cAMP signaling pathway
            hsa04080(135)  Neuroactive ligand-receptor interaction
            hsa04270(135)  Vascular smooth muscle contraction
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01E OTHER CARDIAC PREPARATIONS
                C01EB Other cardiac preparations
                 C01EB21 Regadenoson
                  D05711  Regadenoson (USAN) &lt;US&gt;
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adenosine
                ADORA2A
                 D05711  Regadenoson (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05711
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05711
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05711
DBLINKS     CAS: 875148-45-1
            PubChem: 47207372
            LigandBox: D05711
ATOM        29
            1   C1y C    15.5793  -13.9947
            2   C1y C    16.9687  -13.9947
            3   C1y C    17.3980  -12.6733
            4   O2x O    16.2740  -11.8566
            5   C1y C    15.1500  -12.6733
            6   O1a O    14.8846  -15.1979
            7   O1a O    17.6634  -15.1979
            8   N4y N    18.7076  -12.2478
            9   C1b C    13.8404  -12.2478
            10  O1a O    12.8040  -13.1808
            11  C8y C    19.7359  -13.1900
            12  C8y C    20.9490  -12.5043
            13  N5x N    20.6718  -11.1386
            14  C8x C    19.2873  -10.9802
            15  N5x N    19.7232  -14.5794
            16  C8y C    20.9199  -15.2850
            17  N5x N    22.2026  -14.5993
            18  C8y C    22.1459  -13.2100
            19  N1a N    23.3527  -12.4870
            20  N4y N    20.9596  -16.7036
            21  N5x N    19.8393  -17.5667
            22  C8x C    20.3141  -18.8989
            23  C8y C    21.7278  -18.9286
            24  C8x C    22.1267  -17.5023
            25  O5a O    21.6773  -21.3345
            26  C5a C    22.3971  -20.1461
            27  N1b N    23.7865  -20.1461
            28  C1a C    24.4926  -21.3684
            29  O0  O    15.4700  -20.6500
BOND        31
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     1   6 1 #Down
            7     2   7 1 #Down
            8     3   8 1 #Up
            9     5   9 1 #Up
            10    9  10 1
            11    8  11 1
            12   11  12 1
            13   12  13 1
            14   13  14 2
            15    8  14 1
            16   11  15 2
            17   15  16 1
            18   16  17 2
            19   17  18 1
            20   12  18 2
            21   18  19 1
            22   16  20 1
            23   20  21 1
            24   21  22 2
            25   22  23 1
            26   23  24 2
            27   20  24 1
            28   25  26 2
            29   23  26 1
            30   26  27 1
            31   27  28 1
///
